Nakanishi Inc. (TYO:7716)
1,862.00
+21.00 (1.14%)
May 16, 2025, 3:30 PM JST
Nakanishi Revenue
Nakanishi had revenue of 18.54B JPY in the quarter ending March 31, 2025, with 2.11% growth. This brings the company's revenue in the last twelve months to 77.42B, up 20.53% year-over-year. In the year 2024, Nakanishi had annual revenue of 77.04B with 29.06% growth.
Revenue (ttm)
77.42B
Revenue Growth
+20.53%
P/S Ratio
2.01
Revenue / Employee
35.52M
Employees
2,180
Market Cap
155.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77.04B | 17.35B | 29.06% |
Dec 31, 2023 | 59.69B | 11.02B | 22.64% |
Dec 31, 2022 | 48.67B | 3.81B | 8.50% |
Dec 31, 2021 | 44.86B | 11.80B | 35.70% |
Dec 31, 2020 | 33.06B | -2.36B | -6.67% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 869.37B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |